LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

High-Sensitivity Troponin Demonstrates Potential for Diagnosing Acute Coronary Syndrome

By LabMedica International staff writers
Posted on 24 Sep 2024

Chest pain is a common yet difficult symptom for general practitioners to assess, as it can stem from both serious and benign conditions. Now, a new study has found that high-sensitivity troponin tests have the potential to diagnose acute coronary syndrome in primary care settings.

In the study, researchers at the Leiden University Medical Center (Leiden, The Netherlands) evaluated the effectiveness of various risk assessment tools, including clinical decision rules and troponin tests, in helping general practitioners rule out acute coronary syndrome in patients presenting with chest pain. They conducted a systematic review of studies involving adult patients with chest pain in primary care. The review included studies that assessed the diagnostic accuracy of different clinical decision rules and troponin point-of-care tests, both conventional and high-sensitivity, for identifying acute coronary syndrome, including heart attacks. These tools were compared to the unaided clinical judgment of general practitioners.


Image: High-sensitivity troponin has shown promise in diagnosing acute coronary syndrome in primary care settings (Photo courtesy of 123RF)
Image: High-sensitivity troponin has shown promise in diagnosing acute coronary syndrome in primary care settings (Photo courtesy of 123RF)

The review, which included 14 studies, revealed that some clinical decision rules without troponin improved safety. However, none consistently outperformed the unaided judgment of general practitioners in ruling out acute coronary syndrome. Conventional troponin tests, when used alone, did not meet the required diagnostic accuracy, making them less reliable in primary care. High-sensitivity troponin tests demonstrated the greatest diagnostic accuracy but require further prospective validation in primary care before being recommended for widespread use. While these tests show promise, they are not yet ready to replace clinical judgment or be used independently without additional validation.

Related Links:
Leiden University Medical Center


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Silver Member
Quality Control Material
Multichem ID-B

Latest Molecular Diagnostics News

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis
24 Sep 2024  |   Molecular Diagnostics

New Gene Tool to Enable Earlier Detection and Treatment of Cardiometabolic Diseases
24 Sep 2024  |   Molecular Diagnostics

Genetic Tool Predicts Lithium Responsiveness in Bipolar Disorder Patients
24 Sep 2024  |   Molecular Diagnostics



PURITAN MEDICAL